3D Co-Culture Scaffold Model for Metastasis Drug Screening
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional 2D cancer cell cultures fail to accurately predict cancer metastasis and drug responses due to the absence of a 3D extracellular matrix, while animal models are costly and unsuitable for high-throughput drug screening.
Innovation Solution
A spatially-patterned 3D co-culture model using scaffolds composed of natural and synthetic polymers, decellularized extracellular matrix, and minerals to mimic the in vivo environment, allowing for the assessment of metastatic characteristics and drug responses.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If 2D tissue culture plastic is used for cancer cell culture, then the culture setup is simple and cost-effective, but the model fails to predict cancer metastasis and shows poor correlation with in vivo drug responses due to absence of 3D extracellular matrix
Solution Approach 1:
The patent transitions from conventional 2D tissue culture to a 3D co-culture model using scaffold structures. Cancer cells and target tissue cells are cultured on separate 3D scaffolds that can be positioned in spatial relationships (concentric, adjacent, surrounded) to mimic in vivo metastatic environments, thereby improving metastasis prediction accuracy while maintaining experimental controllability
Solution Approach 2:
The model segments different cell types (cancer cells and target tissue cells) onto separate 3D scaffolds, allowing independent culture conditions and controlled spatial arrangement. This segmentation enables systematic study of metastatic interactions while simplifying the overall system design compared to complex animal models
2Reliability
If animal models are used to study cancer metastasis, then physiological relevance is improved, but cost and time requirements increase significantly and high-throughput screening becomes unsuitable
Solution Approach 1:
The patent creates simplified in vitro copies of in vivo metastatic environments using 3D scaffolds populated with cancer cells and target tissue cells. These cultured models replicate key physiological features of metastasis (3D matrix, cell-cell interactions, spatial organization) without requiring animal subjects, enabling high-throughput screening while maintaining physiological relevance
Solution Approach 2:
The 3D scaffold-based models use relatively inexpensive, disposable culture systems compared to animal models. Each scaffold assembly can be used for a defined period and then discarded, enabling rapid iteration and high-throughput experimentation without the ethical, temporal, and financial constraints of animal studies
Data Source
AI summary
Engineered tissue models based on three-dimensional (3D) scaffolds, also referred to herein as tissue-engineered 3D models, can be used as in vitro diagnostic and drug screening tools for predicting, preventing and/or treating cancer metastases.